Target intelligence / Profile preview

Bet1 Golgi vesicular membrane trafficking protein (BET1)

Target
BET1
Molecular classification
SNARE protein, Vesicular transport protein, Type II membrane protein
01

Overview

Bet1 Golgi vesicular membrane trafficking protein (BET1) is a SNARE family membrane protein required for vesicular transport from the endoplasmic reticulum (ER) to the Golgi complex[2][3][5]. BET1 contributes to docking and fusion of ER-derived vesicles with the cis-Golgi membrane and forms part of the multi-protein SNARE complex essential for this process. Mutations in the BET1 gene disrupt intracellular trafficking, and have been shown to cause severe congenital muscular dystrophy and epilepsy, highlighting its relevance in normal secretory pathway functioning and protein glycosylation. BET1 interacts with proteins including Syntaxin-5, SEC22b, GOSR2, and also with ERGIC-53, the latter of which is important for correct protein localization. BET1 is not a current therapeutic target or drug receptor, but defects in its function can cause human disease due to impaired vesicular trafficking[1][2][3][5].

Other names
BET1 homologhBET1Golgi vesicular membrane-trafficking protein p18Bet1p homologHBET1MDRPblocked early in transport 1 homolog
02

Mechanism of action

Not applicable; there are currently no drugs known to directly target this protein

03

Biological functions

Vesicular transport from endoplasmic reticulum to GolgiDocking of ER-derived vesicles with the cis-Golgi membraneMembrane fusion
04

Disease associations

Muscular dystrophy (specifically congenital muscular dystrophy with rapid progression)EpilepsyPossibly ceroid lipofuscinosis (neuronal)Other diseases linked to protein trafficking defects in secretory pathway

Beyond the preview

Go deeper on Bet1 Golgi vesicular membrane trafficking protein (BET1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bet1 Golgi vesicular membrane trafficking protein (BET1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call